Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Paterson, David L.
and
McCormack, Joseph G.
2003.
More Evidence of the Benefits of Rational Antimicrobial Use in Clinical Practice.
Infection Control & Hospital Epidemiology,
Vol. 24,
Issue. 9,
p.
642.
Furuno, Jon P.
Harris, Anthony D.
Wright, Marc-Oliver
McGregor, Jessina C.
Venezia, Richard A.
Zhu, Jingkun
and
Perencevich, Eli N.
2004.
Prediction rules to identify patients with methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci upon hospital admission.
American Journal of Infection Control,
Vol. 32,
Issue. 8,
p.
436.
LaPlante, Kerry L.
and
Rybak, Michael J.
2004.
Impact of High-InoculumStaphylococcus aureuson the Activities of Nafcillin, Vancomycin, Linezolid, and Daptomycin, Alone and in Combination with Gentamicin, in an In Vitro Pharmacodynamic Model.
Antimicrobial Agents and Chemotherapy,
Vol. 48,
Issue. 12,
p.
4665.
Smith, Philip W.
and
Mylotte, Joseph M.
2005.
Nursing Home-Acquired Bloodstream Infection.
Infection Control & Hospital Epidemiology,
Vol. 26,
Issue. 10,
p.
833.
Hess, Donavon J
Garni, Robb M
Henry-Stanley, Michelle J
and
Wells, Carol L
2005.
ESCHERICHIA COLI MODULATES EXTRAINTESTINAL SPREAD OF STAPHYLOCOCCUS AUREUS.
Shock,
Vol. 24,
Issue. 4,
p.
376.
Glasgow, Tiffany S.
Young, Paul C.
Wallin, Jordan
Kwok, Carolyn
Stoddard, Greg
Firth, Sean
Samore, Matthew
and
Byington, Carrie L.
2005.
Association of Intrapartum Antibiotic Exposure and Late-Onset Serious Bacterial Infections in Infants.
Pediatrics,
Vol. 116,
Issue. 3,
p.
696.
Banning, Maggi
2005.
Transmission and epidemiology of MRSA: current perspectives.
British Journal of Nursing,
Vol. 14,
Issue. 10,
p.
548.
Weigelt, John
Itani, Kamal
Stevens, Dennis
Lau, William
Dryden, Matthew
and
Knirsch, Charles
2005.
Linezolid versus Vancomycin in Treatment of Complicated Skin and Soft Tissue Infections.
Antimicrobial Agents and Chemotherapy,
Vol. 49,
Issue. 6,
p.
2260.
Lodise, Thomas P.
and
McKinnon, Peggy S.
2005.
Clinical and economic impact of methicillin resistance in patients with Staphylococcus aureus bacteremia.
Diagnostic Microbiology and Infectious Disease,
Vol. 52,
Issue. 2,
p.
113.
McGregor, J. C.
Kim, P. W.
Perencevich, E. N.
Bradham, D. D.
Furuno, J. P.
Kaye, K. S.
Fink, J. C.
Langenberg, P.
Roghmann, M.-C.
and
Harris, A. D.
2005.
Utility of the Chronic Disease Score and Charlson Comorbidity Index as Comorbidity Measures for Use in Epidemiologic Studies of Antibiotic-resistant Organisms.
American Journal of Epidemiology,
Vol. 161,
Issue. 5,
p.
483.
Rybak, Michael J.
and
Pharm.D., Kerry L. LaPlante,
2005.
Community-Associated Methicillin-ResistantStaphylococcus aureus: A Review.
Pharmacotherapy,
Vol. 25,
Issue. 1,
p.
74.
DeRyke, C. Andrew
Lodise, Thomas P.
Rybak, Michael J.
and
McKinnon, Peggy S.
2005.
Epidemiology, Treatment, and Outcomes of Nosocomial Bacteremic Staphylococcus aureus Pneumonia.
Chest,
Vol. 128,
Issue. 3,
p.
1414.
McKinnon, Peggy S
Sorensen, Sonja V
Liu, Larry Z
and
Itani, Kamal MF
2006.
Pharmacoeconomics Impact of Linezolid on Economic Outcomes and Determinants of Cost in a Clinical Trial Evaluating Patients with MRSA Complicated Skin and Soft-Tissue Infections.
Annals of Pharmacotherapy,
Vol. 40,
Issue. 6,
p.
1017.
Gemmell, Curtis G.
Edwards, David I.
Fraise, Adam P.
Gould, F. Kate
Ridgway, Geoff L.
and
Warren, Rod E.
2006.
Guidelines for the prophylaxis and treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in the UK.
Journal of Antimicrobial Chemotherapy,
Vol. 57,
Issue. 4,
p.
589.
Karas, J.A.
Enoch, D.A.
and
Emery, M.M.
2006.
Community-onset healthcare-associated MRSA bacteraemia in a district general hospital.
Journal of Hospital Infection,
Vol. 62,
Issue. 4,
p.
480.
Drew, Richard H.
Kawamoto, Kensaku
and
Adams, Martha B.
2006.
Information technology for optimizing the management of infectious diseases.
American Journal of Health-System Pharmacy,
Vol. 63,
Issue. 10,
p.
957.
Fang, Chi-Tai
Shau, Wen-Yi
Hsueh, Po-Ren
Chen, Yee-Chun
Wang, Jann-Tay
Hung, Chien-Ching
Huang, Loreen Y. L.
and
Chang, Shan-Chwen
2006.
Early empirical glycopeptide therapy for patients with methicillin-resistant Staphylococcus aureus bacteraemia: impact on the outcome.
Journal of Antimicrobial Chemotherapy,
Vol. 57,
Issue. 3,
p.
511.
Lesse, Alan J.
and
Mylotte, Joseph M.
2006.
Clinical and molecular epidemiology of nursing home–associated Staphylococcus aureus bacteremia.
American Journal of Infection Control,
Vol. 34,
Issue. 10,
p.
642.
Maki, Dennis G.
Safdar, Nasia
and
Ebert, Steven C.
2007.
Prevalence, Consequences, and Solutions.
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy,
Vol. 27,
Issue. 10P2,
Lodise, Thomas P.
and
McKinnon, Peggy S.
2007.
Burden of Methicillin‐Resistant Staphylococcus aureus: Focus on Clinical and Economic Outcomes.
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy,
Vol. 27,
Issue. 7,
p.
1001.